The duration of BPC-157 use for bone healing depends on the severity of the injury or surgery and the patients individual response to treatment
By 2024 it exceeded USD 15 billion and is forecast to surpass USD 50 billion by 2030 entirely driven by GLP-1/GIP peptide therapies
The therapy implies the full injury course, for both acute and prolonged periods, early and delayed application (i.e., at 1 min, 15 min, 24 h or 48 h ligation-time)
Work with someone who is certified by the International Peptide Society and understands their complexity and can help you experiment, heal and optimize safely
boosting athletic performance
The Day 5 latency time (seconds), which was averaged from 4 trials, to locate the hidden platform in the water maze was taken as an index of acquisition or learning and a baseline measure